Status:
TERMINATED
Acupuncture in Reducing the Severity of Chemoradiation-induced Mucositis in Patients With Oropharyngeal Cancer
Lead Sponsor:
University of Maryland, Baltimore
Conditions:
Mucositis
Oropharyngeal Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients are asked to be in this study if have oropharyngeal cancer and will be treated with chemotherapy and radiation. This research is being done to find out if acupuncture can reduce the mouth in...
Detailed Description
This is a single-center, randomized controlled pilot clinical trial (n=20) assessing the efficacy, feasibility and safety of acupuncture in reducing the severity of chemoradiation-induced oral mucosit...
Eligibility Criteria
Inclusion
- Documented diagnosis of oropharyngeal cancer.
- The patient plans on undergoing external beam radiation with concomitant chemotherapy.
- Eastern Cooperative Group in Oncology (ECOG) performance status 0-3.
- Men and women who are ≥ 18 years old
- The patient is aware of the nature of his or her diagnosis, understands the study regimen, its requirements, risks, and discomforts, and is able and willing to sign an informed consent form.
Exclusion
- Previous history of head and neck cancer.
- Prior acupuncture within the past month.
- Pre-existing active oral infection
- Life expectancy is \< 3 months.
- Plan to go on experimental drug for head and neck cancer in the next 14 weeks.
Key Trial Info
Start Date :
December 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2015
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT01883908
Start Date
December 1 2012
End Date
February 1 2015
Last Update
November 7 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Maryland Marlene & Stewart Greenebaum Cancer Center
Baltimore, Maryland, United States, 21201